Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Lam Research (LRCX) Stock Near Record High After Oregon Expansion and AI Chip Boom: Price Targets, Forecasts and Risks

Lam Research (LRCX) Stock Near Record High After Oregon Expansion and AI Chip Boom: Price Targets, Forecasts and Risks

As of December 11, 2025, Lam Research Corporation is trading near record highs after a year‑long surge powered by artificial‑intelligence chip demand and a fresh expansion in Oregon’s “Silicon Forest.” The stock recently pushed into the high‑$160s, setting new 52‑week highs and more than doubling in 2025, far outpacing the broader technology market. MarketWatch+1
SoFi Technologies (SOFI) Stock Forecast 2025–2030: Can the Fintech Darling Keep Climbing After Its 100% Rally?

SoFi Technologies (SOFI) Stock Forecast 2025–2030: Can the Fintech Darling Keep Climbing After Its 100% Rally?

SoFi Technologies Inc. has turned into one of 2025’s standout fintech winners. The neobank’s stock has roughly doubled this year, powered by record earnings, rapid member growth and a renewed push into crypto and blockchain — but also weighed down, lately, by concerns over rich valuation and a fresh $1.5 billion share offering. 24/7 Wall St.+2Simply Wall St+2
11 December 2025
Analog Devices (ADI) Stock Near Record Highs After Q4 2025 Beat: Earnings, Forecasts and What Comes Next

Analog Devices (ADI) Stock Near Record Highs After Q4 2025 Beat: Earnings, Forecasts and What Comes Next

Analog Devices, Inc. stock is hovering just below record highs after a powerful string of catalysts that started on November 21, 2025. Since flagging its appearance at the UBS Global Technology and AI Conference and then delivering a beat-and-raise fiscal Q4 2025 report, the analog chip leader has attracted fresh attention from both Wall Street and quant screens.
AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie Inc. has quietly turned into one of 2025’s standout large‑cap pharma stories. Shares are up roughly a mid‑20% percentage year‑to‑date, outpacing the broader market, powered by booming sales of Skyrizi and Rinvoq, a fresh dividend hike, and a string of oncology milestones — capped by an HSBC upgrade that just put AbbVie on the firm’s “preferred buys” list for 2026. Barchart.com+224/7 Wall St.+2
1 795 796 797 798 799 891
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Walt Disney

NYSE: DIS 94 / 100
#2 BUY

AerCap

NYSE: AER 92 / 100
#3 TACTICAL BUY

Advanced Micro Devices

NASDAQ: AMD 90 / 100
#4 BUY ON WEAKNESS

Arista Networks

NYSE: ANET 88 / 100
#5 SPECULATIVE BUY

Albemarle

NYSE: ALB 85 / 100
View full portfolio
Editorial model selection. Not personalised advice.